Tag: Amgen
Target: Novo targeting compounded obesity drugs and Amgen ‘at risk’ launchNew Title: Novo Targets...
Hello, everyone! It's great to be here with you today. We hope you're all doing well and ready to dive into some interesting news. Today, we have some updates on Novo Nordisk and Amgen...
Exploring R&D Strategies of Amgen, Biogen, and Takeda for Challenging Targets
Amgen, Biogen, and Takeda are three biopharma companies facing challenges in developing treatments for obesity and Alzheimer's disease. At the STAT 2024 Summit in Boston, leaders from these companies discussed their research and development...